Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Biophytis

Biophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for €4 Million
From Biophytis
Via AccessWire
Topics Bonds
Exposures Debt Markets
Tickers BPTS
Biophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress
From Biophytis
Via AccessWire
Tickers BPTS
Biophytis: Results of the Combined General Meeting on June 21, 2022
From Biophytis
Via AccessWire
Tickers BPTS
Biophytis Presents Preclinical Efficacy Data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a Rare Neuromuscular Disease
From Biophytis
Via AccessWire
Biophytis: Convening of Another Combined General Meeting at a Later Date
From Biophytis
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Regulatory
Tickers BPTS
Biophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June
From Biophytis
Via AccessWire
Exposures COVID-19
Tickers BPTS
Biophytis: Biophytis Presents Sarconeos (BIO101) Development Program in Sarcopenia at the 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston April 20-22, 2022
From Biophytis
Via AccessWire
Exposures COVID-19
Tickers BPTS
Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives
From Biophytis
Via AccessWire
Topics Initial Public Offering
Exposures COVID-19 Securities Market
Tickers BPTS
Biophytis Provides Updates on Sarconeos (BIO101) Clinical Development
From Biophytis
Via AccessWire
Exposures COVID-19 Product Safety
Tickers BPTS
Biophytis Appoints Philippe Rousseau as Chief Financial Officer
From Biophytis
Via AccessWire
Tickers BPTS
Biophytis will Participate in a Key Workshop on Functional Limitations for the Elderly
From Biophytis
Via AccessWire
Exposures COVID-19
Tickers BPTS
Biophytis Received Approval from ANVISA (Brazil) to Give Access to Sarconeos (BIO101) to Hospitalized COVID-19 Patients through an Expanded Access Program
From Biophytis
Via AccessWire
Exposures COVID-19
Tickers BPTS
Biophytis Announces the Drawing of the Last Tranche of ORNANE Under the 2020 Atlas Contract for €3 Million
From Biophytis
Via AccessWire
Topics Bonds
Exposures Debt Markets
Tickers BPTS
Biophytis to Meet with FDA to Advance Sarconeos (BIO101) Development in Sarcopenia from Phase 2 to Phase 3
From Biophytis
Via AccessWire
Exposures COVID-19 Product Safety
Tickers BPTS
Biophytis Obtains a New 10M€ Loan Structure With Kreos Capital
From Biophytis
Via AccessWire
Topics Bonds Regulatory Compliance
Exposures COVID-19 Debt Markets Legal
Tickers BPTS
Biophytis Announces US Centers to Restart Recruitment for the COVA Phase 2-3 Study with Sarconeos (BIO101) in COVID-19
From Biophytis
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Product Safety
Tickers BPTS
Biophytis to Report Restated Financial Statements for Previous Periods and as of June 30, 2021
From Biophytis
Via AccessWire
Topics Bonds Derivatives Regulatory Compliance
Exposures COVID-19 Debt Markets Derivatives
Tickers BPTS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.